Portfolio company
Gnubio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures droplet-based DNA sequencing technology for clinical diagnostic laboratories and medical research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nunabio
This company develops enzymatic technology for the synthesis of complex DNA sequences for customers in the biotechnology, pharmaceutical and materials science sectors.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
Genapsys
This company develops semiconductor-based DNA sequencing hardware and microfluidic chips for academic researchers, pharmaceutical firms and clinical laboratories.
NuvinkaDx
This company develops and manufactures immunodiagnostic and molecular diagnostic products for clinical laboratories and healthcare distributors.
Dropworks
This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
Ultima
This biotechnology company develops high-throughput DNA sequencing systems and consumable reagents for clinical researchers and medical diagnostic laboratories.
